

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1287, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Assessing the long-term impact of using HAART
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. :


Long-term androgen suppression impact on QOL "acceptable"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. :




Inhaled budesonide in children: no long-term impact on growth?
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :